Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
AK-119 by Akaal Pharma for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
AK-119 is under clinical development by Akaal Pharma and currently in Phase II for Atopic Dermatitis (Atopic Eczema). According to...
Data Insights
AK-119 by Akaal Pharma for Multiple Sclerosis: Likelihood of Approval
AK-119 is under clinical development by Akaal Pharma and currently in Phase I for Multiple Sclerosis. According to GlobalData, Phase...